Andri Papakonstantinou
Overview
Explore the profile of Andri Papakonstantinou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
166
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Papakonstantinou A, Villacampa G, Navarro V, Oliveira M, Valachis A, Pascual T, et al.
EClinicalMedicine
. 2025 Mar;
81:103116.
PMID: 40034565
Background: Multiple trials have evaluated escalation strategies of endocrine therapy for early breast cancer, including ovarian function suppression (OFS) and aromatase inhibitors (AI) in premenopausal patients and extended endocrine therapy....
2.
Graberg T, Papakonstantinou A, de Flon F, Shabo I, Morgell A, Linder-Straglitto C, et al.
Rare Tumors
. 2025 Mar;
17:20363613251324973.
PMID: 40026783
Angiosarcoma, an aggressive sarcoma subtype originating from lymphatic or vascular endothelial cells, is rare, constituting less than 2% of all soft tissue sarcomas. Predominantly affecting adult and elderly patients, it...
3.
Matikas A, Papakonstantinou A, Loibl S, Steger G, Untch M, Johansson H, et al.
Lancet Reg Health Eur
. 2024 Dec;
49:101162.
PMID: 39703564
Background: It is unclear whether some patients with high-risk breast cancer do not warrant adjuvant dose-dense chemotherapy due to small expected absolute benefit. Methods: The phase 3 PANTHER trial (NCT00798070)...
4.
Chen Y, Su Y, Cao X, Siavelis I, Leo I, Zeng J, et al.
Adv Sci (Weinh)
. 2024 Sep;
11(41):e2404510.
PMID: 39257029
Synovial Sarcomas (SS) are characterized by the presence of the SS18::SSX fusion gene, which protein product induce chromatin changes through remodeling of the BAF complex. To elucidate the genomic events...
5.
Villacampa G, Navarro V, Matikas A, Ribeiro J, Schettini F, Tolosa P, et al.
JAMA Oncol
. 2024 Aug;
10(10):1331-1341.
PMID: 39207778
Importance: Recent studies have investigated the combination of immune checkpoint inhibitors (ICIs) with (neo)adjuvant chemotherapy in early-stage breast cancer. However, there is an ongoing debate about the optimal approach for...
6.
Frezza A, Leonard H, Aggerholm-Pedersen N, Badalamenti G, Baili P, Baldi G, et al.
PLoS One
. 2024 Aug;
19(8):e0308387.
PMID: 39133752
Introduction: Epithelioid hemangioendothelioma (EHE) is an ultra-rare sarcoma, marked by distinctive molecular and pathological features and with a variable clinical behavior. Its natural history is still partially understood, reliable prognostic...
7.
Panet F, Papakonstantinou A, Borrell M, Vivancos J, Vivancos A, Oliveira M
NPJ Breast Cancer
. 2024 Jun;
10(1):50.
PMID: 38898045
Circulating free tumor DNA (ctDNA) analysis is gaining popularity in precision oncology, particularly in metastatic breast cancer, as it provides non-invasive, real-time tumor information to complement tissue biopsies, allowing for...
8.
Hompland I, Boye K, Wiedswang A, Papakonstantinou A, Rosok B, Joensuu H, et al.
Acta Oncol
. 2024 May;
63:288-293.
PMID: 38712513
Introduction: Metastatic gastrointestinal stromal tumour (GIST) is considered incurable, and life-long treatment with tyrosine kinase inhibitors is recommended. We investigated whether selected patients with metastatic GIST may remain in durable...
9.
Ofverholm I, Wallander K, Haglund C, Chellappa V, Wejde J, Gellerbring A, et al.
Clin Cancer Res
. 2024 Apr;
30(12):2647-2658.
PMID: 38573684
Purpose: Tumor classification is a key component in personalized cancer care. For soft-tissue and bone tumors, this classification is currently based primarily on morphology assessment and IHC staining. However, these...
10.
Berndsen M, Renberg S, Holmebakk T, Hancke E, Puls F, Karlsson F, et al.
Br J Surg
. 2023 Sep;
110(12):1857-1862.
PMID: 37758514
Background: Gastrointestinal stromal tumour (GIST) is the most common intra-abdominal sarcoma. Risk classification systems, commonly the modified National Institutes of Health consensus criteria, identify tumour properties relating to patient outcomes....